Wockhardt Ltd (WOCKPHARMA):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Wockhardt Ltd (WOCKPHARMA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9937
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Wockhardt Ltd (Wockhardt) is a pharmaceutical company that manufactures and markets vaccines, active pharmaceutical ingredients, pharmaceutical and recombinant bio-pharmaceutical formulations. The company’s product portfolio caters to various therapeutic areas including orthopedics, dental care, dermatology, rheumatology, gynecology, pediatrics, cardiology, pain management, nephrology, neurology and diabetes, among others. Wockhardt holds expertise in biotechnology research with a focus on gene cloning; and development of production strains and expression of proteins. It also concentrates its research in generics, novel drug delivery system; and new chemical entities. The company has presence in India, the UK, Switzerland and British Virgin Islands. Wockhardt is headquartered in Mumbai, Maharashtra, India.

Wockhardt Ltd (WOCKPHARMA) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Wockhardt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Wockhardt Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Wockhardt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Wockhardt Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Wockhardt Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Wockhardt Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Pharmadax Enters into Agreement with Wockhardt Bio 11
Equity Offering 12
Wockhardt Plans to Raise USD155.3 Million in Equity Offering 12
Wockhardt Bio Completes IPO For US$2.5 Million 13
Debt Offering 14
Wockhardt May Raise USD300 Million in Public Offering of Bonds 14
Asset Transactions 15
Danone Completes Acquisition Of Nutrition Business Of Wockhardt For US$228 Million 15
Wockhardt Ltd – Key Competitors 16
Wockhardt Ltd – Key Employees 17
Wockhardt Ltd – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 20
Financial Announcements 20
Aug 04, 2018: Wockhardt QlfYL9 Net Sales at Rs.7,008 crore, up by 73% over QIFYL8 20
May 04, 2018: Wockhardt Q4FY18 Net Sales at Rs.1,018 crore and FY 17-18 Sales at Rs. 3,937 crore 21
Jan 29, 2018: Wockhardt Q3 FY1 8 Net Sales at Rs. 1,0 05 crore , EBITDA at Rs. 45 crore grew 6 times Q- o -Q and 2 .5 times Y -o -Y 23
Oct 30, 2017: Wockhardt Q2FY18 Net Sales at Rs.1,022 crore, grew by 15% Quarter-on-Quarter 24
May 04, 2017: Wockhardt Q4FY17 Net Sales at Rs.864 crore and FY16-17 at Rs. 4,015 crore 26
Jan 24, 2017: Wockhardt Q3FY17 Net Sales at Rs.995 crore, EBITDA at Rs. 18 cr 28
Legal and Regulatory 29
Jun 22, 2017: Wockhardt and its Subsidiaries settle with Teva and its Affiliate a commercial litigation in the High Court, London 29
May 29, 2017: WOCKPHARMA Announces Update on Aurangabad facility 30
Mar 07, 2017: WOCKPHARMA Provides Update on Aurangabad facility 31
Jan 05, 2017: Wockhardt Provides Update On Its Manufacturing Facility Ankaleshwar, Gujarat 32
Clinical Trials 33
Apr 03, 2017: Wockhardt Receives Acknowledgement of its Breakthrough Superdrug Antibiotic WCK 5222 For Phase III Clinical Trial From US FDA 33
Other Significant Developments 35
Jul 29, 2018: Wockhardt sets up its first manufacturing and R&D unit in Middle East 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Wockhardt Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Wockhardt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Wockhardt Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Wockhardt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Wockhardt Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Wockhardt Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Pharmadax Enters into Agreement with Wockhardt Bio 11
Wockhardt Plans to Raise USD155.3 Million in Equity Offering 12
Wockhardt Bio Completes IPO For US$2.5 Million 13
Wockhardt May Raise USD300 Million in Public Offering of Bonds 14
Danone Completes Acquisition Of Nutrition Business Of Wockhardt For US$228 Million 15
Wockhardt Ltd, Key Competitors 16
Wockhardt Ltd, Key Employees 17
Wockhardt Ltd, Other Locations 18
Wockhardt Ltd, Subsidiaries 18

List of Figures
Wockhardt Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Wockhardt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Wockhardt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Wockhardt Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Wockhardt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Wockhardt Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Wockhardt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Wockhardt Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Wockhardt Ltd (WOCKPHARMA):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Telefonica, S.A.:戦略・SWOT・企業財務分析
    Telefonica, S.A. - Strategy, SWOT and Corporate Finance Report Summary Telefonica, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Petrol dd Ljubljana (PETG):企業の財務・戦略的SWOT分析
    Petrol dd Ljubljana (PETG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Cargolux Airlines International S.A.:企業の戦略的SWOT分析
    Cargolux Airlines International S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Cooperative Energy:企業の戦略的SWOT分析
    Cooperative Energy - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Vivimed Labs Ltd (VIVIMEDLAB):企業の財務・戦略的SWOT分析
    Vivimed Labs Ltd (VIVIMEDLAB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Lockheed Martin Corporation:企業のM&A・事業提携・投資動向
    Lockheed Martin Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Lockheed Martin Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Cardiac Science Corp:企業の戦略的SWOT分析
    Cardiac Science Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Thaivivat Insurance Public Company Limited
    Thaivivat Insurance Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Thaivivat Insurance Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Ligand Pharmaceuticals Inc (LGND):製薬・医療:M&Aディール及び事業提携情報
    Summary Ligand Pharmaceuticals Inc (Ligand) develops and acquires technologies that help in discovery and development of medicines. The company employs research technologies including nuclear receptor assays, formulation science, high throughput computer screening, antibody discovery technologies an …
  • LGC Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary LGC Ltd (LGC), formerly LGC (Teddington) Ltd is a life sciences measurement and testing company that offers reference materials, genomics solutions and analytical testing products and services. The company’s products comprise DNA extraction instrumentation, DNA extraction kits, Douglas scien …
  • Molnlycke Health Care AB:医療機器:M&Aディール及び事業提携情報
    Summary Molnlycke Health Care AB (Molnlycke), a subsidiary of Investor AB, is a medical device company. The company manufactures and markets single-use surgical and wound care products. It offers a range of surgical and wound care products; infection prevention solutions; prevention and treatment so …
  • Microvision Inc (MVIS):企業の財務・戦略的SWOT分析
    Summary Microvision Inc (Microvision) is a technology company that provides scanning technology solutions. The company offers technology solutions including PicoP scanning technology, an ultra-miniature laser projection and imaging solutions based on the laser beam scanning methodology. It also prov …
  • QuadGraphics, Inc. (QUAD):企業の財務・戦略的SWOT分析
    QuadGraphics, Inc. (QUAD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Senseonics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Senseonics Inc (Senseonics), a subsidiary of Senseonics Holdings Inc, is a medical device company that designs, develops and commercializes of glucose monitoring products. Its products, Eversense and Eversense XL, are implantable continuous glucose monitoring (CGM) systems that help people w …
  • Georgia Power Co:企業の発電所・SWOT分析2018
    Georgia Power Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (e …
  • RigNet Inc (RNET):企業の財務・戦略的SWOT分析
    RigNet Inc (RNET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Euro-Diagnostica AB:医療機器:M&Aディール及び事業提携情報
    Summary Euro-Diagnostica AB (Euro Diagnostica) is a medical device company that manufactures and markets purified antigens and antibodies. The company offers blood based solutions, developed to aid clinicians in diagnosis, prognosis, monitoring and treatment of autoimmune diseases. It offers product …
  • Surgical Care Affiliates LLC (SCAI):企業の財務・戦略的SWOT分析
    Summary Surgical Care Affiliates LLC (SCA), a subsidiary of UnitedHealth Group Inc is a healthcare organization that offers patient care and healthcare services. The organization's services include scheduling optimization, physician governance and engagement, case costing, profitability analysis and …
  • Nanobiotix SA (NANO):企業の財務・戦略的SWOT分析
    Summary Nanobiotix SA (Nanobiotix) is a late stage clinical company which develops nanomedicines for the treatment of cancers. The company develops first-in-class products utilizing its proprietary technology NanoXray, based on the physical mode of action of nanoparticles that increase the X-rays do …
  • Crown Van Gelder N.V.:企業の戦略・SWOT・財務分析
    Crown Van Gelder N.V. - Strategy, SWOT and Corporate Finance Report Summary Crown Van Gelder N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆